Vyvanse and Glucose Intolerance in Children With ADHD and Obesity
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials
| City: |
|
Durham |
| State: |
|
North Carolina |
| Zip Code: |
|
27705 |
| Conditions: |
|
Attention Deficit Hyperactivity Disorder - Glucose Intolerance - Obesity |
| Purpose: |
|
The purpose of this study to assess the effects of chronic administration of Vyvanse
(lis-dexamphetamine) on glucose metabolism in a sample of children and adolescents with
Attention Deficit Hyperactivity Disorder (ADHD) who also have glucose intolerance and are
obese.
|
| Study Summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- male or female, ages between 8 and 17
- Body Mass Index > 30
- fasting blood sugar between 90-100 mg/dl
- 2 hour post prandial >140 <180 mg/dl
- meets criteria for a diagnosis of ADHD, any subtype
Exclusion Criteria:
- known cardiovascular disease or diabetes
- structural cardiac abnormalities, abnormal ECGs, family history of sudden death
- positive urine drug screen
- fasting blood sugar level > 126 mg/dl
- HbA1c > 6.5 %
- Weight > 300 lbs
|
| NCT ID: |
|
NCT01017263 |
| Primary Contact: |
|
Principal Investigator
Scott H Kollins, PhD
Duke University
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Durham, North Carolina 27705
United States
There is no listed contact information for this specific location.
Site Status: N/A |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 18, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|